Literature DB >> 10477621

Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta.

M Schmidt1, H G Pauels, N Lügering, A Lügering, W Domschke, T Kucharzik.   

Abstract

Glucocorticoids (GC) are potent anti-inflammatory and immunosuppressive agents that act on a variety of immune cells, including monocytes and macrophages. However, the exact cellular mechanisms underlying this anti-inflammatory capacity are still unknown. In our study, we determined the induction of apoptosis by GC in human monocytes. Peripheral blood monocytes were isolated by density centrifugation methods with a purity of >90% and were cultured in RPMI 1640 medium. Monocyte apoptosis was determined by four independent methods, including annexin-V staining, TUNEL, DNA-laddering, and typical morphology by means of transmission electron microscopy. TNF-alpha and IL-1beta were measured by ELISA. GC receptor was blocked with mifepristone. Caspase 3 was inhibited with caspase-3 inhibitor (DEVD-CHO). Stimulation with different GC at therapeutic concentrations resulted in monocyte apoptosis in a time- and dose-dependent manner. Necrosis was excluded by propidium iodide staining. Proinflammatory cytokines such as IL-1beta and TNF-alpha were down-regulated by GC treatment. Continuous treatment of monocytes with IL-1beta, but not with TNF-alpha, could almost completely prevent GC-induced cell death. The addition of mifepristone or caspase-3 inhibitor could partially abrogate GC-induced apoptosis as well as GC-induced inhibition of IL-1beta. This is the first study to demonstrate induction of apoptosis by GC in human monocytes. GC-induced monocyte apoptosis may be partially mediated through effects on IL-1beta production. It is conceivable that GC exert their anti-inflammatory capacity in various diseases, at least in part, by the induction of apoptosis in monocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477621

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  Molecular mechanisms of glucocorticoid action: what is important?

Authors:  R Newton
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

2.  Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.

Authors:  Martin K Hunn; Evelyn Bauer; Catherine E Wood; Olivier Gasser; Marina Dzhelali; Lindsay R Ancelet; Brigitta Mester; Katrina J Sharples; Michael P Findlay; David A Hamilton; Ian F Hermans
Journal:  J Neurooncol       Date:  2014-10-31       Impact factor: 4.130

3.  The effect of dexamethasone on the generation of plasma DNA from dead and dying cells.

Authors:  Ning Jiang; David S Pisetsky
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

4.  Myeloid cells in infantile hemangioma.

Authors:  Matthew R Ritter; John Reinisch; Sheila Fallon Friedlander; Martin Friedlander
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

5.  Splenic micronodular T-cell/histiocyte-rich large B-cell lymphoma: effect of prior corticosteroid therapy.

Authors:  Elena Kan; Itai Levy; Daniel Benharroch
Journal:  Virchows Arch       Date:  2009-09-09       Impact factor: 4.064

6.  Characterization of porous, dexamethasone-releasing polyurethane coatings for glucose sensors.

Authors:  Suzana G Vallejo-Heligon; Bruce Klitzman; William M Reichert
Journal:  Acta Biomater       Date:  2014-07-25       Impact factor: 8.947

7.  Molecular basis of rifampicin-induced inhibition of anti-CD95-induced apoptosis of peripheral blood T lymphocytes: the role of CD95 ligand and FLIPs.

Authors:  Sastry Gollapudi; Suman Jaidka; Sudhir Gupta
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

8.  Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids.

Authors:  F S Kalthoff; J Chung; P Musser; A Stuetz
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

9.  Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury.

Authors:  Jin-Moo Lee; Ping Yan; Qingli Xiao; Shawei Chen; Kuang-Yung Lee; Chung Y Hsu; Jan Xu
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

10.  Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals.

Authors:  H Cullup; P G Middleton; G Duggan; J S Conn; A M Dickinson
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.